Related Experiment Video
Updated: Apr 15, 2026

08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
872
Leukemia in children: getting back to school-part 1
1Naval Medical Center Portsmouth, Pediatric Hematology/Oncology, Portsmouth, VA.
NASN School Nurse (Print)
|March 28, 2015
Summary
Childhood acute lymphoblastic leukemia (ALL) survival rates are increasing. Returning to school after treatment is crucial for recovery and normalization, with strategies benefiting many children.
Area of Science:
- Pediatric Oncology
- Childhood Cancer Survivorship
- Educational Psychology
Background:
- Cancer remains a leading cause of childhood disease-related death.
- Over 80% of diagnosed children and adolescents now survive at least 5 years.
- Significant survival improvements are noted in acute lymphoblastic leukemia (ALL).
Purpose of the Study:
- To review the diagnosis, prognosis, and treatment of childhood ALL, including Philadelphia chromosome-positive ALL.
- To provide accessible information for school personnel and parents regarding ALL.
- To share insights into school reintegration challenges and strategies for pediatric cancer survivors.
Main Methods:
- Literature review on childhood ALL diagnosis, prognosis, and treatment.
- Case study detailing a child's transition to school post-leukemia treatment.
- Analysis of accommodations and strategies for school reintegration.
Main Results:
- Increased survival rates for childhood ALL, particularly Philadelphia chromosome-positive ALL.
- School reintegration is vital for normalizing life post-cancer treatment.
- Identified strategies and accommodations can support children with physical challenges during school reentry.
Conclusions:
- Effective communication and education are key for school personnel and parents managing childhood ALL.
- Successful school reentry requires tailored accommodations and support systems.
- The discussed strategies offer a transferable model for supporting pediatric cancer survivors and children with physical challenges in educational settings.
Related Concept Videos
Bone Marrow Sampling and Transplants
2.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.7K
Disorders of Leukocytes
2.5K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.5K
Stem Cell Therapy for Tissue Regeneration
4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Differentiation of Common Myeloid Progenitor Cells
4.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K

